SCHEMBL3408077

SCHEMBL3408077

CN(CCN1CCC(c2ccccc2)(N2CCCC2)CC1)Cc1cccc2[nH]ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.48
SIGMAR1 Q99720 5/20 0.47
OPRM1 P35372 4/20 0.40
OPRL1 P41146 2/20 0.40
ACHE P22303 2/20 0.39
SLC6A4 P31645 2/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
CYP2B6 P20813 1/20 0.38
SLC6A2 P23975 1/20 0.38
PRCP P42785 1/20 0.38
SLC6A3 Q01959 1/20 0.38
GRIN1 Q05586 1/20 0.38
KCNH2 Q12809 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
OPRD1 P41143 1/20 0.38
HTR2A P28223 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405547 0.89 OPRM1 (0.51) BCHESIGMAR1OPRM1OPRL1ACHE
SCHEMBL3403549 0.86 OPRL1 (0.49) BCHESIGMAR1OPRM1OPRL1ACHE
SCHEMBL3409432 0.81 SIGMAR1 (0.43) SIGMAR1OPRM1SLC6A4GRIN2DGRIN3B
SCHEMBL3405033 0.80 HTR1A (0.46) BCHESIGMAR1OPRM1OPRL1ACHE
SCHEMBL4103306 0.80 SIGMAR1 (0.43) SIGMAR1OPRM1SLC6A4GRIN2DGRIN3B
SCHEMBL3409919 0.77 BCHE (0.47) BCHESIGMAR1OPRM1OPRL1ACHE
SCHEMBL3410692 0.76 OPRL1 (0.65) BCHESIGMAR1OPRM1OPRL1ACHE
SCHEMBL3409607 0.73 ALDH1A1 (0.46)
SCHEMBL3403655 0.71 HRH3 (0.43) SIGMAR1SLC6A4GRIN2DGRIN3BCYP2B6
SCHEMBL2331745 0.70 HRH3 (0.56) SIGMAR1OPRM1SLC6A4GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US claimed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP claimed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US claimed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US claimed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215828-A1 Substituted indole derivatives IDO1, IDO2, TPH1 BCHE 2840/4885SIGMAR1 235/4885OPRM1 30/4885
US-20130116283-A1 Substituted indole derivatives IDO1, IDO2, TPH1 BCHE 2840/4885SIGMAR1 235/4885OPRM1 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.